Company Filing History:
4 out of 10 
1 out of 346 
1 out of 1 Years Active: 2013-2019
Title: The Innovative Contributions of Tobias Knaute
Introduction
Tobias Knaute is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of six patents to his name, Knaute's work has garnered attention in the scientific community.
Latest Patents
Among his latest patents are the NPR-B agonists, which disclose novel compounds exhibiting NPR-B agonistic activity. These preferred compounds are linear peptides containing 8-13 conventional or non-conventional L- or D-amino acid residues connected to one another via peptide bonds. This innovative approach has the potential to advance therapeutic options in various medical applications.
Career Highlights
Knaute has worked with notable companies such as Shire Orphan Therapies GmbH and Alcon Research, Ltd. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Some of his coworkers include Frank Osterkamp and Heiko Hawlisch. Their collaborative efforts have further enhanced the impact of Knaute's inventions and research.
Conclusion
Tobias Knaute's innovative work in developing NPR-B agonists and his contributions to the pharmaceutical industry highlight his role as a significant inventor. His patents and collaborations continue to influence advancements in medical research and therapy.